Description
A new long-acting glucagon-like peptide-1 (GLP-1) analogue from Novo Nordisk for glycemic control in adults with type 2 diabetes who have received and/or sulfonylureas in addition to diet control and exercise. And reduce the risk of major cardiovascular adverse events (cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes with cardiovascular disease.
- Fat loss
- ozempic
- semaglutide
- weight dissolving
Production Capacity:
5000000
Delivery Timeframe:
Immediate
Incoterms:
DDU - Delivered Duty Unpaid
FOB - Free on Board
Packaging Details:
1.5ml x 1 sryinge per box 3ml x 1 sryinge per box
More about
Nuro Beauty technology co.,ltd
10-50
Employees
500K - 1M
Sales volume (USD)
100%
% Export sales
Year
Established
Business type
- Industry / Manufacturer
- Representative / Agent
- Distributor / Wholesaler
Keywords
- 玻尿酸
- 蛋白线
- 美容产品
Contact and location
-
youki ********
-
+86 1********
-
shijiazhuang / | China